(TP53), widely known as the “guardian of the genome,” is one of the most frequently altered genes in human cancer. While its canonical tumor-suppressive ...

At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...

Discover 25 unexpected facts that will change how you see the world. From frozen lobsters to massive clouds, these ...

Inocras and the Broad Institute analyzed 8,000+ TCGA cancer genomes to uncover new drivers and create a harmonized dataset ...

The Breakthrough Prize Foundation today announced the winners of the 2026 Breakthrough Prizes, honoring scientists whose discoveries are significantly driving growth of human knowledge. In the Life ...

Artificial intelligence (AI) is emerging as a powerful force in breast cancer research, but the future of personalized care will not be written by ...

Artificial intelligence (AI) is emerging as a powerful force in breast cancer research, but the future of personalized care will not be written by ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

Findings uncover the architecture of a key viral complex, showing how RNA interaction and protein assembly drive replication and offering a framework for antiviral research.

As I am writing this, my DNA is changing. And, as you read this, so is yours. People tend to assume that the genes we inherit from our parents are a fixed blueprint for our growth and development, ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2023. The plant body is formed by small clusters of stem cells located ...